Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells

Anti-Cancer Drugs

Volumn 18, Issue 6, 2007, Pages 669-676

  Gagliano, Nicoletta ^a   Moscheni, Claudia ^a   Torri, Carlo ^a   Donetti, Elena ^a   Magnani, Ivana ^a   Costa, Francesco ^a   Nowicky, Wassil ^b   Gioia, Magda ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Ukrainian Anti Cancer Institute   (Austria)

Author keywords

Apoptosis; Connexin 43; Cytochrome c; Glial fibrillary acidic protein; Glioblastoma; Ukrain

Indexed keywords

CONNEXIN 43; CYTOCHROME C; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; UKRAIN;

APOPTOSIS; ARTICLE; CANCER INVASION; CELLULAR DISTRIBUTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOPLASM; FLUORESCENCE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MORPHOLOGICAL ADAPTATION; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SOLID TUMOR; UPREGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BERBERINE ALKALOIDS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CONNEXIN 43; DOSE-RESPONSE RELATIONSHIP, DRUG; GAP JUNCTIONS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, TRANSMISSION; PHENANTHRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 34548357033     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32808bf9ec     Document Type: Article

References (39)

1. Kleihues P, Soylemezoglu F, Schauble B, Scheithauer BW, Burger PC. Histopathology, classification, and grading of gliomas. Glia 1995; 15:211-221.
2. Sehgal A. Molecular changes during the genesis of human gliomas. Semin Surg Oncol 1998; 14:3-12.
3. Duffy PE, Huang YY, Rapport MM. The relationship of GFAP to cell shape, motility and differentiation of human astrocytoma cells. Exp Cell Res 1982; 139:145-157.
4. Rutka JT, Murakami M, Dirks PB, Hubbard SL, Becker LE, Fukuyama K, et al. Role of glial filaments in cells and tumors of glial origin: a review. J Neurosurg 1997; 87:420-430.
5. Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, Boynton AL. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (CX43). Cancer Res 1998; 58:5089-5096.
6. Goodenough DA, Goliger JA, Paul DL. Connexins, connexons, and intercellular communication. Annu Rev Biochem 1996; 65:475-502.
7. Yamasaki H, Naus CC. Role of connexin genes in growth control. Carcinogenesis 1996; 17:1199-1213.
8. Shinoura N, Chen L, Wani MA, Kim YG, Larson JJ, Warnick RE, et al. Protein and messenger RNA expression of connexin43 in astrocytomas: implications in brain tumor gene therapy. J Neurosurg 1996; 84:839-845.
9. Scholz C, Wieder T, Starck L, Essmann F, Schulze-Osthoff K, Dorken B, et al. Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway. Oncogene 2005; 24:1904-1913.
10. Kretmair H. Hypericum perforatum, St. John's wort. Pharmazie 1950;5:85-88.
11. Susak YM, Zemskov VS, Yaremchuk OY, Kravchenco OB, Yatsyk IM, Korsh OB. Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer. Drugs Exp Clin Res 1996; 22:115-122.
12. Uglianitsa KN, Nefyodov LI, Brzosko W. Evaluation of the efficacy of Ukrain in the treatment of breast cancer: clinical and laboratory studies. Drugs Exp Clin Res 1998; 24:231-239.
13. Uglianitsa KN, Nechiporenko NA, Nefyodov LI, Brzosko WJ. Ukrain therapy of stage T1N0M0 bladder cancer patients. Drugs Exp Clin Res 1998; 24:227-230.
14. Zemskov V, Prokopchuk O, Susak Y, Zemskov S, Tkachenko O, Hodysh Y, et al. Efficacy of Ukrain in the treatment of pancreatic cancer. Langenbecks Arch 2002; 387:84-89.
15. Ernst E, Schmidt K. Ukrain-a new cancer cure? A systematic review of randomised clinical trials. BMC Cancer 2005; 5:69.
16. Liepins A, Nowicky JW. Activation of spleen cell lytic activity by the alkaloid thiophosphoric acid derivative: Ukrain. Int J Immunopharmacol 1992; 14:1437-1442.
17. Liepins A, Nowicky JW, Bustamante JO, Lam E. Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain NSC-631570. Drugs Exp Clin Res 1996; 22:73-79.
18. 2/M arrest and apoptosis in human epidermoid carcinoma cell lines by semisynthetic drug Ukrain. Anticancer Res 2000; 20:3163-3167.
19. Habermehel D, Kammerer B, Handrick R, Eldh T, Gruber C, Cordes G, et al. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway. BMC Cancer 2006; 6:14.
20. Gagliano N, Moscheni C, Torri C, Magnani I, Bertelli AAE, Nowicky W, et al. Effect of Ukrain on matrix metalloproteinase 2 (MMP-2) and secreted protein acidic and rich in cysteine (SPARC) expression in human glioblastoma cells. Anti-Cancer Drugs 2006; 17:189-194.
21. Magnani I, Guerneri S, Pollo B, Cirenei N, Colombo BM, Broggi G, et al. Increasing complexity of the karyotype in 50 human gliomas. Cancer Genet Cytogenet 1994; 75:77-89.
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
23. Burnette WM. 'Western blotting': electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981; 112:195-203.
24. Misra A, Chattopadhyay P, Dinda AK, Sarkar C, Mahapatra AK, Hasnain SE, et al. Extensive intratumor heterogeneity in primary glial tumors as a result of locus non-specific genomic alterations. J Neurooncol 2000; 48:1-12.
25. Lipinski CA, Tran NL, Bay C, Kloss J, McDonough WS, Beaudry C, et al. Differential role of proline-rich tyrosine kinase 2 and focal adhesion kinase in determining glioblastoma migration and proliferation. Mol Cancer Res 2003; 1:323-332.
26. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer 1988; 62:2152-2165.
27. Shapiro WR. Current therapy for brain tumors. Arch Neurol 1999; 56:429-432.
28. Inagaki M, Nakamura Y, Takeda M, Nishimura T, Inagaki N. Glial fibrillary acidic protein: dynamic property and regulation by phosphorylation. Brain Pathol 1994; 4:239-243.
29. Shiras A, Bohsale A, Shepal V, Shukla R, Baburao VS, Prabhakara K, et al. A unique model system for tumor progression in GBM comprising two developed human neuro-epithelial cell lines with differential transforming potential and coexpressing neuronal and glial markers. Neoplasia 2003; 5:520-532.
30. Toda M, Miura M, Asou T, Sugiyama I, Kawase T, Uyemura K. Suppression of glial tumor growth by expression of glial fibrillary acidic protein. Neurochem Res 1999; 24:339-343.
31. Asklunnd T, Appelskog IB, Ammerpohl O, Ekstrom TJ, Almqvist PM. Histone deacetylase inhibitor 4-phenilbutyrate modulates glial fibrillary acidic protein and connexin 43 expression, and enhances gap-junction communication, in human glioblastoma cells. Eur J Cancer 2004; 40:1073-1081.
32. Elobeid A, Bongcam-Rudloff E, Westermark B, Nister M. Effects of inducible glial fibrillary acidic protein on glioma cell motility and proliferation. J Neurosci Res 2000; 60:245-256.
33. Goldman RD, Zackroff RV, Steinert PM. Intermediate filaments: overview. In: Goldman RD, Steinert PM, (editors). Cellular and molecular biology of intermediate filaments. New York: Plenum; 1990: pp. 3-20.
34. Soroceanu L, Manning TJ, Sontheimer H. Reduced expression of connexin-43 and functional gap junction coupling in human gliomas. Glia 2001;33:107-117.
35. Hossain MZ, Boynton AL. Regulation of Cx43 gap junctions: the gatekeeper and the password. Sci STKE 2000; PE1.
36. Trosko JE, Goodman JI. Intercellular communication may facilitate apoptosis: implications for tumor promotion. Mol Carcinog 1994; 11:8-12.
37. Huang RP, Hossain M, Huang R, Gano J, Fan Y, Boynton AL. Expression of CX43 enhances sensitivity of human glioblastoma cells to chemotherapeutic drugs. Int J Cancer 2001; 92:130-138.
38. Huang R, Liu YG, Lin Y, Fan Y, Boynton A, Yang D, Huang RP. Enhanced apoptosis under low serum conditions in human glioblastoma cells by connexin 43 (CX43). Mol Carcinog 2001; 32:128-138.
39. VanEngeland M, Nieland LJW, Ramaekers FCS, Schutte B, Reutelingsperger CPM. Annexin-V affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998; 31:1-9.